Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 569

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

Hanai, Hiroyuki, Iida, Takayuki, Takeuchi, Ken, Watanabe, Fumitoshi, Maruyama, Yasuhiko, Andoh, Akira, Tsujikawa, Tomoyuki, Fujiyama, Yosihihide, Mitsuyama, Keiichi, Sata, Michio, Yamada, Masami, Iwaoka, Yasushi, Kanke, Kazunari, Hiraishi, Hideyuki, Hirayama, Kazuhisa, Arai, Hajime, Yoshii, Shigehito, Uchijima, Masato, Nagata, Toshi, Koide, Yukio·2006·Clinical Gastroenterology and Hepatology
DOI 10.1016/j.cgh.2006.08.008
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2006.08.008

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 32

  1. Head, 2003, Inflammatory bowel disease part I: ulcerative colitis-pathophysiology and conventional and alternative treatment options, Altern Med Rev, 8, 247
  2. Boyko, 1987, Risk of ulcerative colitis among former and current cigarette smokers, N Engl J Med, 316, 707, 10.1056/NEJM198703193161202 · DOI
  3. Rampton, 1981, Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs, Postgrad Med J, 57, 297, 10.1136/pgmj.57.667.297 · DOI
  4. Kurina, 2001, Depression and anxiety in people with inflammatory bowel disease, J. Epidemiol Community Health, 55, 716, 10.1136/jech.55.10.716 · DOI · Paper page
  5. Weber, 2000, Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinase α and β, Gastroenterology, 119, 1209, 10.1053/gast.2000.19458 · DOI · Paper page
  6. Bantel, 2000, Mesalazine inhibits activation of transcription factor NF-κB in inflamed mucosa of patients with ulcerative colitis, Am J Gastroenterol, 95, 3452, 10.1111/j.1572-0241.2000.03360.x · DOI
  7. Xu, 2004, Drug therapy for ulcerative colitis, World J Gastroenterol, 10, 2311, 10.3748/wjg.v10.i16.2311 · DOI
  8. Hanauer, 2004, Medical therapy of ulcerative colitis, Gastroenterology, 126, 1582, 10.1053/j.gastro.2004.02.071 · DOI
  9. Hanauer, 2006, Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities, Inflamm Bowel Dis, 12, S3, 10.1097/01.MIB.0000195385.19268.68 · DOI
  10. Kornbluth, 1995, How effective is current medical therapy for severe ulcerative colitis?, J Clin Gastroenterol, 20, 280, 10.1097/00004836-199506000-00004 · DOI
  11. Taffet, 1983, Sulphasalazine-adverse effects and desensitization, Dig Dis Sci, 28, 833, 10.1007/BF01296907 · DOI
  12. Present, 2000, How to do without steroids in inflammatory bowel disease, Inflamm Bowel Dis, 6, 48, 10.1097/00054725-200002000-00009 · DOI
  13. Devos, 2003, Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy, Dermatology, 206, 388, 10.1159/000069965 · DOI
  14. Jiang, 1996, Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines, Nutr Cancer, 26, 111, 10.1080/01635589609514468 · DOI
  15. Singh, 1996, Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell, Cancer Lett, 107, 109, 10.1016/0304-3835(96)04357-1 · DOI
  16. Huang, 1991, Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells, Proc Natl Avad Sci USA, 88, 5292, 10.1073/pnas.88.12.5292 · DOI · Paper page
  17. Xu, 1997, Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells, Exp Hematol, 25, 413
  18. Joe, 1997, Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin, Mol Cell Biochem, 169, 125, 10.1023/A:1006877928703 · DOI
  19. Singh, 1995, Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane), J Biol Chem, 270, 2495
  20. Kumar, 1998, Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of molecules and of nuclear factor-κB activation, Biochem Pharmacol, 55, 775, 10.1016/S0006-2952(97)00557-1 · DOI
  21. Jobin, 1999, Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity, J Immunol, 163, 3474, 10.4049/jimmunol.163.6.3474 · DOI
  22. Sugimoto, 2002, Curcumin ameliorates trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice, Gastroenterology, 123, 1912, 10.1053/gast.2002.37050 · DOI · Paper page
  23. Rachmilewitz, 1989, Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial, Br Med J, 298, 82, 10.1136/bmj.298.6666.82 · DOI · Paper page
  24. Schreiber, 1998, Activation of nuclear factor κB inflammatory bowel disease, Gut, 42, 477, 10.1136/gut.42.4.477 · DOI
  25. Neurath, 1998, Role of NF-κB in immune and inflammatory responses in the gut, Gut, 43, 856, 10.1136/gut.43.6.856 · DOI · Paper page
  26. Rogler, 1998, Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa, Gastroenterology, 115, 357, 10.1016/S0016-5085(98)70202-1 · DOI · Paper page
  27. Lim, 2004, Controversies with aminosalicylates in inflammatory bowel disease, Rev Gastroenterol Disord, 4, 104
  28. McIntyre, 1988, Balsalazide in the maintenance treatment of patients with ulcerative colitis: a double-blind comparison with sulphasalazine, Aliment Pharmacol Ther, 2, 237, 10.1111/j.1365-2036.1988.tb00693.x · DOI
  29. Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high risk or pre-malignant lesions, Anticancer Res, 21, 2895
  30. Squires, 2003, Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/proteinkinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells, Bichem Pharmacol, 65, 361, 10.1016/S0006-2952(02)01517-4 · DOI
  31. Chan, 1998, In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties, Biochem Pharmacol, 55, 1955, 10.1016/S0006-2952(98)00114-2 · DOI · Paper page
  32. Chainani-Wu, 2003, Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa), J Altern Complement Med, 9, 161, 10.1089/107555303321223035 · DOI · Paper page

Cited by

Metadata

Authors
Hanai, H., Iida, T., Takeuchi, K., Watanabe, F., Maruyama, Y., Andoh, A., Tsujikawa, T., Fujiyama, Y., Mitsuyama, K., Sata, M., Yamada, M., Iwaoka, Y., Kanke, K., Hiraishi, H., Hirayama, K., Arai, H., Yoshii, S., Uchijima, M., Nagata, T., & Koide, Y.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2006-12
Volume
4
Issue
12
Pages
1502-1506
ISSN
1542-3565
DOI
10.1016/j.cgh.2006.08.008
Cited by
569
References
1
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.